USPTO 2015–2025 USPTO PatentsView US Corporation

Clinical Reference Laboratory, Inc.

USPTO PatentsView assignee record - 5 granted patents across 14 technology areas, recorded in grant years 2017–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: G16H (Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data).

RSS updates for this company

The verdict

According to USPTO PatentsView, Clinical ranks #45,734 of 49,997 tracked US assignees by granted-patent volume, with 5 patents across 14 technology areas.

#45,734
of 49,997 US assignees by volume
Top 27%
by Innovation Score (43.9/100)
18.6
avg claims per patent
+100%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R45734 · US Corporation #45,734 · 5 grants

GRANTS-MICRO · BOTTOM-DECILE · PHOTO-FINISH · CPC-FOCUS · INNOV-PAR · CLAIMS-RICH · TYPE-USCORP · VEL-SURGE · BOOK-FULL

  • GRANTS-MICRO 5 grants
  • BOTTOM-DECILE #45,734/49,997
  • PHOTO-FINISH Clementia Pharmaceut…
  • CPC-FOCUS G16H · 14 areas
  • INNOV-PAR 43.9/100
  • CLAIMS-RICH 18.6 claims/avg
  • TYPE-USCORP US Corporation
  • VEL-SURGE +100% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: Clementia Pharmaceuticals Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Innovation-score neighbourhood around Clinical

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Clinical's Innovation Score is 43.9/100 (top 27% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Where Clinical's grants concentrate

Clinical Reference Laboratory, Inc. is a focused PatentsView assignee: 14 CPC subclasses with 60% of grants classified under G16H (Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data). Peak complete grant year is 2023 (2 grants) versus a trough of 1 in 2017. By volume, Clinical sits between Clementia Pharmaceuticals Inc. and Cloud9 Technologies, LLC.

Clinical's three-year grant acceleration

Clinical Reference Laboratory, Inc. shows 2 grants in 2022–2024 against only 0 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Who files at Clinical's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Clinical holds 5 patents at rank #45,873, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Clinical

By rank, the assignees closest to #45,873 in granted patent volume.

Leaders in G16H (Healthcare Informatics)

Other assignees with the most granted patents in Clinical's primary technology class.

Clinical's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

44 Top 27% higher than 73% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

0.511.522.5 201720232025 2
USPTO utility patent grants by year · 2017–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2017–2019 baseline. Full figures in the table below.

View data table
Clinical Reference Laboratory, Inc. patent grants by year, 2015–2025
Year Patents Granted Share of Period
2017 1 20.0%
2023 2 40.0%
2025partial year 2 40.0%

Which technologies does Clinical Reference Laboratory, Inc. patent most?

Top 14 of 14 technology areas

Where it ranks

Overall rank by patents

#45,734

of 49,997 tracked assignees

Innovation Score

43.9 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

Clinical Reference Laboratory, Inc.'s patent record in context - here's where to go next.

  • Clinical Reference Laboratory, Inc.'s lead technology class is G16H (Healthcare Informatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR THE Handling OR Processing OF Medical OR Healthcare Data), 60% of its portfolio - see every assignee active in that class. Explore G16H
  • Ranked #45,734 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Clinical Reference Laboratory, Inc. against Clementia Pharmaceuticals Inc., an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 43.9/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.